Hadassah

Kidney Donor With Hepatitis C Enables Hadassah Patient to Thrive

Tuesday, Jul 31 2018

Shuki Mizrachi has a rare genetic disease that causes his kidneys to fail. At age 42, he had already undergone years of dialysis and three kidney transplants. His body was no longer able to undergo dialysis and there were no healthy kidneys available for transplant.

That’s when Hadassah Medical Organization nephrologist Dr. Keren Tzukert offered Mr. Mizrachi a chance to be the first Israeli patient to receive a kidney from a donor with Hepatitis C. “When you are drowning and someone offers you a life raft, you take it--even if there is a small hole,” Mr. Mizrachi says.

Mr. Mizrachi received antiviral medications to combat the Hepatitis C immediately following his transplant. A year later, he is still healthy, with no sign of hepatitis and a functioning kidney.

Hadassah was one of the first medical centers in the world to perform an organ transplant from a donor with hepatitis. “The success of antiviral medications in combating Hepatitis C made such transplants a viable option,” explains Prof. Rifaat Safadi, head of Hadassah’s Liver Unit. “Without these medications, we would have had to reject these kidneys. Now they can save our patients’ lives.”

To date, three additional patients have received kidneys from Hepatitis C positive donors at Hadassah.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Aug 15 2019

Argentinian Neurosurgeon Shares His Love for Working at Hadassah

Many years ago, neurosurgeon Andrés Vargas, born in Tucumán, Argentina, chose to live in Israel and practice medicine at Hadassah Hospital Ein Kerem.

READ MORE ›
alt_text

Wednesday, Aug 14 2019

A Hadassah Cystic Fibrosis Expert Advises the Panamanian Government

Dr. Malena Cohen, a pediatric pulmonary specialist at the Hadassah Medical Organization, traveled to Panama last week to explore the idea of opening the first cystic fibrosis (CF) center there.

READ MORE ›
alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More